Endogenous Bak inhibitors Mcl-1 and Bcl-xL: differential impact on TRAIL resistance in Bax-deficient carcinoma
内源性 Bak 抑制剂 Mcl-1 和 Bcl-xL：对 Bax 缺陷型癌症中 TRAIL 抗性的不同影响
期刊:Journal of Cell Biology
影响因子:7.4
doi:10.1083/jcb.200912070
Bernhard Gillissen, Jana Wendt, Antje Richter, Anja Richter, Annika Müer, Tim Overkamp, Nina Gebhardt, Robert Preissner, Claus Belka, Bernd Dörken, Peter T Daniel
